Loading...
OTCM
THCBF
Market cap2mUSD
May 19, Last price  
0.00USD
Name

THC Biomed Intl Ltd

Chart & Performance

D1W1MN
OTCM:THCBF chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
191.75%
Revenues
0k
-100.00%
0003,08601,5591,1127940000500,00059,876925,3391,489,6034,178,1793,774,3213,339,9970
Net income
0k
P
-684,958-1,194,835-2,365,055-1,321,916-886,198-538,128-3,804,834-2,381,350-8,114,516-371,058-215,342-3,062,056-536,340-604,867-12,458,908-12,699,347-161,590-6,359,254-3,065,8480
CFO
0k
P
-406,584-227,110-576,075-609,931-511,191-256,139-452,893-1,233,007-473,456-431,505-190,497-395,723-1,148,294-1,380,640-2,431,542-1,866,107114,933-1,010,247-1,857,1870

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

THC Biomed Intl Ltd., headquartered in Kelowna, Canada, cultivates and distributes cannabis products for both medical and recreational consumption throughout the nation. The company's diverse offerings include cannabis-infused beverage shots, gummies, and biscuits, all sold under its THC KISS brand, as well as traditional pure cannabis sticks. This enterprise was established in 2012.
IPO date
Jan 09, 1984
Employees
35
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑072022‑072021‑072020‑072019‑072018‑072017‑072016‑07
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT